Jin Medical International Ltd. (ZJYL)
NASDAQ:ZJYL
US Market
Holding ZJYL?
Track your performance easily

Jin Medical International Ltd. (ZJYL) Income Statement

59 Followers

Jin Medical International Ltd. Income Statement

Last quarter (Q ), Jin Medical International Ltd.'s total revenue was $―, a decrease of ― from previous quarter. In Q, Jin Medical International Ltd.'s net income was $―. See Jin Medical International Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Sep 22Sep 21Sep 20
Total Revenue
-$ 19.82M$ 19.19M$ 20.76M$ 16.19M
Cost of Revenue
-$ 13.04M$ 12.99M$ 14.40M$ 10.70M
Gross Profit
-$ 6.78M$ 6.20M$ 6.36M$ 5.50M
Operating Expense
-$ 3.92M$ 4.07M$ 3.73M$ 3.14M
Operating Income
-$ 2.87M$ 2.13M$ 2.63M$ 2.35M
Net Non Operating Interest Income Expense
-$ 182.68K$ 181.60K$ -9.49K$ -112.40K
Other Income Expense
-$ -222.40K$ 430.51K$ 258.34K$ 110.88K
Pretax Income
-$ 3.22M$ 2.74M$ 2.88M$ 2.35M
Tax Provision
-$ 343.71K$ 36.11K$ 248.64K$ 147.15K
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
-$ 2.88M$ 2.71M$ 2.63M$ 2.21M
Basic EPS
-$ 0.02$ 0.35$ 0.34$ 0.28
Diluted EPS
-$ 0.02$ 0.35$ 0.34$ 0.28
Basic Average Shares
-$ 145.14M$ 7.75M$ 7.75M$ 8.00M
Diluted Average Shares
-$ 145.14M$ 7.75M$ 7.75M$ 8.00M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
-$ 16.95M$ 17.06M$ 18.13M$ 13.84M
Net Income From Continuing And Discontinued Operation
-$ 2.88M$ 2.71M$ 2.63M$ 2.21M
Normalized Income
-$ 2.37M$ 2.52M$ 2.57M$ 2.22M
Interest Expense
---$ 9.49K$ 112.40K
EBIT
-$ 3.22M$ 2.13M$ 2.89M$ 2.47M
EBITDA
-$ 3.45M$ 2.49M$ 3.24M$ 2.80M
Currency in USD

Jin Medical International Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis